Full article: Pharmacokinetic bioequivalence, safety and acceptability of Ornibel®, a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring® (etonogestrel/ethinylestradiol 11.7/2.7 mg)
![Color, Scent and Size: Exploring Women's Preferences Around Design Characteristics of Drug-Releasing Vaginal Rings | SpringerLink Color, Scent and Size: Exploring Women's Preferences Around Design Characteristics of Drug-Releasing Vaginal Rings | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10461-022-03596-7/MediaObjects/10461_2022_3596_Fig1_HTML.png)
Color, Scent and Size: Exploring Women's Preferences Around Design Characteristics of Drug-Releasing Vaginal Rings | SpringerLink
![Progesterone vaginal ring as a new contraceptive option for lactating mothers: Evidence from a multicenter non-randomized comparative clinical trial in India - Contraception Progesterone vaginal ring as a new contraceptive option for lactating mothers: Evidence from a multicenter non-randomized comparative clinical trial in India - Contraception](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0806b983-275d-431e-8c1e-f96bd8c27621/gr1.jpg)
Progesterone vaginal ring as a new contraceptive option for lactating mothers: Evidence from a multicenter non-randomized comparative clinical trial in India - Contraception
![PDF) Pharmacokinetic bioequivalence, safety and acceptability of Ornibel ® , a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring ® (etonogestrel/ethinylestradiol 11.7/2.7 mg) PDF) Pharmacokinetic bioequivalence, safety and acceptability of Ornibel ® , a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring ® (etonogestrel/ethinylestradiol 11.7/2.7 mg)](https://www.researchgate.net/profile/Pedro-Antonio-Regidor/publication/322536735/figure/fig7/AS:631624228159523@1527602359630/Etonogestrel-and-ethynilestradiol-mean-plasma-concentration-time-curves-4-weeks-of-use_Q320.jpg)
PDF) Pharmacokinetic bioequivalence, safety and acceptability of Ornibel ® , a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring ® (etonogestrel/ethinylestradiol 11.7/2.7 mg)
![Pharmaceutics | Free Full-Text | The Vaginal Microbiota, Bacterial Biofilms and Polymeric Drug-Releasing Vaginal Rings | HTML Pharmaceutics | Free Full-Text | The Vaginal Microbiota, Bacterial Biofilms and Polymeric Drug-Releasing Vaginal Rings | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-13-00751/article_deploy/html/images/pharmaceutics-13-00751-g001-550.jpg)
Pharmaceutics | Free Full-Text | The Vaginal Microbiota, Bacterial Biofilms and Polymeric Drug-Releasing Vaginal Rings | HTML
![PDF) The contraceptive vaginal ring Ornibel® improves the menstrual cycle profiles in women: data of an observational study PDF) The contraceptive vaginal ring Ornibel® improves the menstrual cycle profiles in women: data of an observational study](https://i1.rgstatic.net/publication/346432899_The_contraceptive_vaginal_ring_OrnibelR_improves_the_menstrual_cycle_profiles_in_women_data_of_an_observational_study/links/5fc6327f299bf1a422c7fae5/largepreview.png)